MSNBC MTP Daily July 11, 2024
We have a ton of developments today in the Coronavirus Vaccine situation. What we do know is encouraging in many waysramping up vaccine production. What we dont know about the effectiveness is terrifying. It makes you wonder if the u. S. Needs to dramatically rethink the current Vaccine Distribution strategy. Lets start with the good news. Today johnson and johnson leased some promising data from its phase three clinical trials. The vaccine is 72 effective in the u. S. At preventing moderate to severe illness. Experts consider that a strong level of protection. Here is the potential worrying n...